Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yusi Hayashida"'
Autor:
Mikio Sugimoto, Xia Zhang, Nobufumi Ueda, Hiroyuki Tsunemori, Rikiya Taoka, Yusi Hayashida, Hiromi Hirama, Yasuyuki Miyauchi, Yuki Matsuoka, Hirohito Naito, Yu Osaki, Yosiyuki Kekehi
Publikováno v:
BMC Urology, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Chronic inflammation is thought to be a major causative factor for the development of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Tadalafil, a phosphodiesterase type 5 inhibitor (PDE5-I), which has
Externí odkaz:
https://doaj.org/article/de3365c2484c48b9a530e3d308d5063c
Autor:
Yasuyuki Miyauchi, Yosiyuki Kekehi, Yusi Hayashida, Rikiya Taoka, Hirohito Naito, Hiroyuki Tsunemori, Nobufumi Ueda, Hiromi Hirama, Yu Osaki, Yuki Matsuoka, Mikio Sugimoto, Xia Zhang
Publikováno v:
BMC Urology
BMC Urology, Vol 19, Iss 1, Pp 1-7 (2019)
BMC Urology, Vol 19, Iss 1, Pp 1-7 (2019)
Background Chronic inflammation is thought to be a major causative factor for the development of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Tadalafil, a phosphodiesterase type 5 inhibitor (PDE5-I), which has been used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf9e2460675a5255d4534fa817cc6728
https://doi.org/10.1186/s12894-019-0525-x
https://doi.org/10.1186/s12894-019-0525-x